Skip to main content
. Author manuscript; available in PMC: 2009 Feb 1.
Published in final edited form as: Br J Psychiatry. 2008 Feb;192:98–105. doi: 10.1192/bjp.bp.107.040113

Table 2.

Table 2a. Lifetime Prevalence of Suicide-Related Outcomes in the WMH Surveys

Table 2b. Lifetime Prevalence of Suicide-Related Outcomes in the WMH Surveys

Total Sample
Ideation Plan Attempt
% (se) (sd) (n) % (se) (sd) (n) % (se) (sd) (n)

The Americas
Colombia 12.4** (0.7) (46.6) (587) 4.1** (0.4) (26.6) (204) 4.7** (0.4) (26.6) (224)
Mexico 8.1* (0.5) (38.0) (488) 3.2 (0.3) (22.8) (192) 2.7 (0.3) (22.8) (166)
USA 15.6** (0.5) (48.2) (1462) 5.4** (0.3) (28.9) (507) 5.0** (0.2) (19.3) (469)
Europe
Belgium 8.4 (0.9) (44.3) (209) 2.7 (0.4) (19.7) (77) 2.5 (0.4) (19.7) (66)
France 12.4** (0.7) (37.7) (391) 4.4** (0.4) (21.5) (143) 3.4 (0.4) (21.5) (115)
Germany 9.7 (0.7) (41.7) (347) 2.2* (0.3) (17.9) (78) 1.7* (0.3) (17.9) (64)
Italy 3.0* (0.3) (20.6) (144) 0.7* (0.1) (6.9) (33) 0.5* (0.1) (6.9) (26)
Netherlands 8.2 (0.6) (29.2) (223) 2.7 (0.5) (24.4) (78) 2.3 (0.3) (14.6) (64)
Spain 4.4* (0.3) (22.2) (272) 1.4* (0.2) (14.8) (84) 1.5* (0.2) (14.8) (80)
Ukraine 8.2* (0.5) (34.4) (389) 2.7 (0.3) (20.6) (126) 1.8* (0.2) (13.7) (80)
Africa & the Middle East
Israel 5.5* (0.3) (20.9) (268) 1.9* (0.2) (13.9) (93) 1.4* (0.2) (13.9) (66)
Lebanon 4.3* (0.6) (32.1) (117) 1.7* (0.4) (21.4) (39) 2.0* (0.3) (16.0) (54)
Nigeria 3.2* (0.2) (16.4) (237) 1.0* (0.1) (8.2) (70) 0.7* (0.1) (8.2) (46)
South Africa 9.1 (0.7) (46.0) (394) 3.8 (0.4) (26.3) (171) 2.9 (0.3) (19.7) (140)
Asia and the Pacific
China 3.1* (0.2) (14.4) (160) 0.9* (0.2) (14.4) (42) 1.0* (0.2) (14.4) (49)
Japan 10.9** (0.5) (24.7) (264) 2.1* (0.3) (14.8) (50) 1.9* (0.3) (14.8) (48)
New Zealand 15.9** (0.5) (56.5) (2212) 5.6** (0.3) (33.9) (814) 4.6** (0.3) (33.9) (688)
  Total 9.2 (0.1) (29.1) (8164) 3.1 (0.1) (29.1) (2801) 2.7 (0.1) (29.1) (2445)

Among Ideators
Plan Attempt Attempt w/o a lifetime plan Attempt with a lifetime plan
% (se) (sd) (n) % (se) (sd) (n) % (se) (sd) (n) % (se) (sd) (n)

The Americas
Colombia 33.2 (2.6) (63.0) (204) 37.8** (2.6) (63.0) (224) 22.7** (3.2) (62.6) (77) 68.3** (3.5) (50.0) (147)
Mexico 39.0** (2.7) (59.6) (192) 33.8 (2.7) (59.6) (166) 16.3 (2.6) (44.7) (48) 61.3 (4.8) (66.5) (118)
USA 34.5 (1.6) (61.2) (507) 31.8 (1.4) (53.5) (469) 19.9** (1.4) (43.3) (185) 54.4 (3.1) (69.8) (284)
Europe
Belgium 32.2 (3.4) (49.2) (77) 29.4 (4.3) (62.2) (66) 12.2 (3.4) (39.1) (16) 65.7 (7.0) (61.4) (50)
France 35.9 (3.1) (61.3) (143) 27.2 (2.9) (57.3) (115) 14.2 (3.1) (48.8) (40) 50.4 (4.6) (55.0) (75)
Germany 22.1* (2.5) (46.6) (78) 17.4* (2.2) (41.0) (64) 4.0* (1.3) (21.3) (14) 64.7 (5.8) (51.2) (50)
Italy 24.6* (4.0) (48.0) (33) 18.2* (4.5) (54.0) (26) 8.2* (3.0) (31.6) (10) 48.8 (11.2) (64.3) (16)
Netherlands 33.4 (4.6) (68.7) (78) 27.6 (3.5) (52.3) (64) 12.0 (3.2) (38.5) (18) 58.6 (7.4) (65.4) (46)
Spain 33.1 (3.8) (62.7) (84) 33.9 (3.1) (51.1) (80) 14.4 (3.4) (46.6) (23) 73.3** (5.8) (53.2) (57)
Ukraine 32.9 (2.5) (49.3) (126) 21.5* (2.7) (53.3) (80) 13.4 (2.3) (37.3) (32) 38.2* (5.0) (56.1) (48)
Africa & the Middle East
Israel 35.3 (3.2) (52.4) (93) 25.0 (2.9) (47.5) (66) 8.3* (2.1) (27.8) (15) 55.5 (5.5) (53.0) (51)
Lebanon 38.4 (5.0) (54.1) (39) 46.4** (5.2) (56.2) (54) 30.1** (6.3) (55.6) (25) 72.4** (6.9) (43.1) (29)
Nigeria 30.1 (3.6) (55.4) (70) 20.9* (3.0) (46.2) (46) 1.9* (0.9) (11.6) (3) 64.8 (7.2) (60.2) (43)
South Africa 41.7** (2.3) (45.7) (171) 31.7 (2.6) (51.6) (140) 11.2 (2.3) (34.3) (33) 60.5 (4.5) (58.8) (107)
Asia and the Pacific
China 29.5 (4.6) (58.2) (42) 32.3 (4.9) (62.0) (49) 26.1** (4.7) (51.1) (28) 47.1 (10.0) (64.8) (21)
Japan 18.8* (2.6) (42.2) (50) 17.0* (2.5) (40.6) (48) 8.8* (2.1) (30.7) (21) 52.1 (7.0) (49.5) (27)
New Zealand 35.1 (1.4) (65.8) (814) 28.8 (1.3) (61.1) (688) 16.6 (1.4) (52.3) (241) 51.2 (2.2) (62.8) (447)
  Total 33.6 (0.7) (63.2) (2801) 29.0 (0.6) (54.2) (2445) 15.4 (0.6) (43.9) (829) 56.0 (1.2) (63.5) (1616)
1

n = 84,850

*

The upper end of the 95% confidence interval of the estimate is below the prevalence estimate for the total sample.

**

The lower end of the 95% confidence interval of the estimate is above the prevalence estimate for the total sample.